Press Release: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 March 2014

Author (Corporate)
Series Title
Series Details 07.03.14
Publication Date 07/03/2014
Content Type

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) gave recommendations on three safety referrals at its March 2014 meeting.
Source Link Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/03/news_detail_002036.jsp&mid=WC0b01ac058004d5c1
Related Links
ESO: Background information: Press Release: PRAC re-examines diacerein and recommends that it remain available with restrictions http://www.europeansources.info/record/press-release-prac-re-examines-diacerein-and-recommends-that-it-remain-available-with-restrictions/
ESO: Background information: Press Release: PRAC recommends restricting use of domperidone http://www.europeansources.info/record/press-release-prac-recommends-restricting-use-of-domperidone/
ESO: Background information: Press Release: PRAC recommends product information of zolpidem be updated with new advice to minimise the risk of next-morning impaired driving ability and mental alertness http://www.europeansources.info/record/press-release-prac-recommends-product-information-of-zolpidem-be-updated-with-new-advice-to-minimise-the-risk-of-next-morning-impaired-driving-ability-and-mental-alertness/
Subject Categories
Countries / Regions